The Centers for Disease Control and Prevention has signed off on use of Pfizer’s COVID vaccine for children ages 12 to 15, clearing the way for shots to begin.
Where You Can Get COVID Vaccines for Kids Ages 12-15 in the Chicago Area A number of health departments across the Chicago area have announced plans to begin vaccines as early as Thursday
Published May 11, 2021 •
Updated on May 11, 2021 at 5:33 pm
NBCUniversal Media, LLC
A number of health departments across the Chicago area have announced plans to begin vaccines as early as Thursday, pending a recommendation from the Centers for Disease Control and Prevention. Don t miss local breaking news and weather! Download our mobile app for iOS or Android and sign up for alerts.
U.S. regulators on Monday expanded use of Pfizer s shot to those as young as 12. The two-dose vaccine was already authorized for use in people 16 and older. But the FDA s decision doesn t mean vaccinations can begin right away.
Vaccine Management Analytics: Will It Be The Next 2021 Data Story?
By Srinivas Kosaraju, Senior Director, Public Sector, Solution Engineers, Tableau Software
As the world enters the second year of the coronavirus pandemic, actionable insights are more critical than ever. They’re even being prioritized in the new National Strategy for COVID-19 Response and Pandemic Preparedness alongside executive orders to evaluate progress, monitor outcomes, and support transparency and equity with Americans. As the world rolls out COVID-19 vaccines, the need for accurate and timely vaccination distribution and uptake data is top-of-mind for government leaders, public health organizations, and healthcare providers everywhere. These metrics are foundational for managing vaccination programs, measuring their effectiveness, and determining our collective progress toward a blanket of herd immunity, as described by Dr. Anthony Fauci, director, National Institute of Allergy and Infectious Diseases
Read later
Audio version
Summary:
Vaccinations are the key to getting to the so-called new normal . Enterprise tech is playing its role in getting the jabs to people s arms, but there s a need to focus on experience-based messaging to counter hesitancy in key communities.
(Pixabay )
The emergence of COVID-19 vaccines is the good news that millions around the world have waited to hear for over a year. But there are those who still harbor (vocal) doubts about their rollout, doubts that need to be overcome if successful mass-vaccination is to be achieved.
A recent study by Kantar Public, polling 7,133 people across the US, UK, France, Italy, India, Germany and The Netherlands, found some striking variations in national attitudes to the prospect of being vaccinated. France and the USA displayed the highest levels of vaccine hesitancy - 40% and 25% respectively - whereas respondents in India, Italy and the UK - 82%, 80% and 76% - are most likely to definitely/probably get the